Pembrolizumab-induced immune related adverse events and survival outcomes in advanced melanoma.

Aleksi Suo,Yin Chan,Winson Y. Cheung,Jose Gerard Monzon,Michael Smylie,John Wt Walker,Donald Morris,Tina Cheng

Pembrolizumab-induced immune related adverse events and survival outcomes in advanced melanoma.

2018

Aleksi Suo
Yin Chan
Winson Y. Cheung
Jose Gerard Monzon
Michael Smylie
John Wt Walker
Donald Morris
Tina Cheng

e21577Background: Anti-PD-1 checkpoint immunotherapies have distinct toxicity profiles that include immune-related adverse events (irAE). Objective response rates (ORR) appear to be higher in patie...

Keywords:

Melanoma
Immune system
Pembrolizumab
Cancer research
Pathology
Adverse effect
Medicine
objective response
Oncology
Toxicity
advanced melanoma
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations